New Rimantadine-Grindeks already available in chemistry shops

New Rimantadine-Grindeks already available in chemistry shops

10/12/2009

JSC Grindeks informs, that starting from December 10, 2009 Rimantadine-Grindeks 50mg N20 tablets, the antiviral medication effective against seasonal influenza, are available in chemistry shops of Latvia. According to the data of World Health Organization, the seasonal influenza in 2010 will become acute earlier than in past years. Rimantadine-Grindeks 50mg N20 tablets will be first product in the anti-viral product portfolio of the Company.

The active substance of Rimantadine-Grindeks is rimantadine hydrochloride and its commonly used chemical name is rimantadine. For the first time, the substance was synthesized in Latvian Institute of Organic Synthesis 40 years ago.

The price of Rimantadine-Grindeks 50mg N20 in the chemistry shops of Latvia will be under 5 Lats per pack.

Chairman of the Board of Grindeks Jānis Romanovskis: “As it is well known, the demand determines the supply; therefore we must offer medications in response to the society needs. In this case – anti-flu medication is required and we can be proud, that we are able to provide effective, high quality product produced according to EU high standard requirements for the fight against seasonal influenza!”

Grindeks also plans to register and manufacture Rimantadine-Grindeks 100mg.

About Grindeks

Grindeks is the leading pharmaceutical company in the Baltic States. The main directions of its operation are research, development, manufacturing and sales of original products, as well as generics and active pharmaceutical ingredients. Grindeks concern consists of four subsidiary companies in Latvia, Estonia and Russia; as well as representatives and representative offices in 14 countries. Products of the company are exported to more than 40 countries and its export comprises more than 96% of the total turnover. The main markets are the Baltic States, Russia and other CIS countries, as well as Japan and USA. The shares of JSC Grindeks are listed in the Official List of “Nasdaq OMX Riga”.

Further information:

Laila Kļaviņa
Head of the Communications Department
JSC Grindeks
E-mail: [email protected]
Phones: +371 67083370, +371 29256012

Related posts

ImgNews4

Grindeks celebrates 75-year anniversary

Today on December 21, JSC Grindeks, the leading pharmaceutical manufacturer in the Baltic States celebrates its 75-year anniversary. Over these 75 years, Grindeks has become...
21/12/2021
magnifiercrossmenu